Diagnosing and Treating Immune Thrombocytopenic Purpura
The group continues their analysis of emergencies by exploring their first hematologic emergency: Immune thrombocytopenic purpura (ITP). They explain how to confirm that the diagnosis is in fact ITP, and subsequently, provide a treatment plan.
Briefing on Geographical Access to Head and Neck Cancer Clinical Trials
FDA Grants Priority Review to Zongertinib for HER2-Mutated NSCLC
New Insights From IDEA-France & HORG: The Prognostic Power of ctDNA and Immunoscore